232 related articles for article (PubMed ID: 23901116)
1. Reexpression of pyruvate kinase M2 in type 1 myofibers correlates with altered glucose metabolism in myotonic dystrophy.
Gao Z; Cooper TA
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13570-5. PubMed ID: 23901116
[TBL] [Abstract][Full Text] [Related]
2. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing dysregulation secondary to skeletal muscle regeneration.
Orengo JP; Ward AJ; Cooper TA
Ann Neurol; 2011 Apr; 69(4):681-90. PubMed ID: 21400563
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
[TBL] [Abstract][Full Text] [Related]
5. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
6. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
[TBL] [Abstract][Full Text] [Related]
7. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy.
Orengo JP; Chambon P; Metzger D; Mosier DR; Snipes GJ; Cooper TA
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2646-51. PubMed ID: 18272483
[TBL] [Abstract][Full Text] [Related]
8. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.
Tang ZZ; Yarotskyy V; Wei L; Sobczak K; Nakamori M; Eichinger K; Moxley RT; Dirksen RT; Thornton CA
Hum Mol Genet; 2012 Mar; 21(6):1312-24. PubMed ID: 22140091
[TBL] [Abstract][Full Text] [Related]
9. Systemic Evaluation of Chimeric LNA/2'-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy.
Christou M; Wengel J; Sokratous K; Kyriacou K; Nikolaou G; Phylactou LA; Mastroyiannopoulos NP
Nucleic Acid Ther; 2020 Apr; 30(2):80-93. PubMed ID: 31873063
[TBL] [Abstract][Full Text] [Related]
10. The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
Ozimski LL; Sabater-Arcis M; Bargiela A; Artero R
Biol Rev Camb Philos Soc; 2021 Apr; 96(2):716-730. PubMed ID: 33269537
[TBL] [Abstract][Full Text] [Related]
11. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.
Santoro M; Masciullo M; Bonvissuto D; Bianchi ML; Michetti F; Silvestri G
Mol Cell Biochem; 2013 Aug; 380(1-2):259-65. PubMed ID: 23666741
[TBL] [Abstract][Full Text] [Related]
13. Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1.
López-Morató M; Brook JD; Wojciechowska M
Front Neurol; 2018; 9():349. PubMed ID: 29867749
[TBL] [Abstract][Full Text] [Related]
14. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
[TBL] [Abstract][Full Text] [Related]
15. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
17. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.
Du H; Cline MS; Osborne RJ; Tuttle DL; Clark TA; Donohue JP; Hall MP; Shiue L; Swanson MS; Thornton CA; Ares M
Nat Struct Mol Biol; 2010 Feb; 17(2):187-93. PubMed ID: 20098426
[TBL] [Abstract][Full Text] [Related]
18. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.
Ward AJ; Rimer M; Killian JM; Dowling JJ; Cooper TA
Hum Mol Genet; 2010 Sep; 19(18):3614-22. PubMed ID: 20603324
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of PDLIM3/ALP, for α-actinin-associated LIM protein 3, is aberrant in persons with myotonic dystrophy.
Ohsawa N; Koebis M; Suo S; Nishino I; Ishiura S
Biochem Biophys Res Commun; 2011 May; 409(1):64-9. PubMed ID: 21549096
[TBL] [Abstract][Full Text] [Related]
20. [Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis].
Furling D
Rinsho Shinkeigaku; 2012; 52(11):1018-22. PubMed ID: 23196502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
